Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Journal of Molecular Neuroscience : MN|January 24, 2003
Pin1: a therapeutic target in Alzheimer neurodegenerationMalika Hamdane, Caroline Smet, Anne-Véronique Sambo, et al.
Acta Neuropathologica Communications|March 3, 2019
The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?Yann Fichou, Youssra K Al-Hilaly, François Devred, et al.
The Journal of Biological Chemistry|March 14, 2024
A selection and optimization strategy for single-domain antibodies targeting the PHF6 linear peptide within the tau intrinsically disordered proteinJustine Mortelecque, Orgeta Zejneli, Séverine Bégard, et al.
Journal of Medicinal Chemistry|October 3, 2017
Modulators of 14-3-3 Protein-Protein InteractionsLoes M Stevers, Eline Sijbesma, Maurizio Botta, et al.
Journal of Biomedical Science|June 16, 2026
Tau profiling of brain extracellular vesicles reveals PHF6 peptide as core for pathological tau seeding in Alzheimer's diseaseMarie Oosterlynck, Laura Fichter, Elodie Leroux, et al.
Nature Communications|August 27, 2016
Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylasesRasheduzzaman Chowdhury, Ivanhoe K H Leung, Ya-Min Tian, et al.
Nature Communications|November 2, 2021
Dynamic interactions and Ca2+-binding modulate the holdase-type chaperone activity of S100B preventing tau aggregation and seedingGuilherme G Moreira, François-Xavier Cantrelle, Andrea Quezada, et al.
Science (New York, N.Y.)|August 29, 2024
Aggregate-selective removal of pathological tau by clustering-activated degradersJonathan Benn, Shi Cheng, Sophie Keeling, et al.
Acta Neuropathologica Communications|September 24, 2015
Tau phosphorylation regulates the interaction between BIN1's SH3 domain and Tau's proline-rich domainYoann Sottejeau, Alexis Bretteville, François-Xavier Cantrelle, et al.
Pageof 13